Company Profile LogoSAGA Diagnostics

Liquid biopsy testing specialists. Ultrasensitive cancer diagnosis and monitoring to 0.001% variant frequency.

Edit IconSuggest an Edit
Oncology
Genetics
Biotechnology
Medical

    Unlock insights on SAGA Diagnostics and 2M+ companies now!

    About SAGA Diagnostics

    SAGA Diagnostics AB is a personalized cancer diagnostics and disease monitoring company focused on molecular genetic analyses of a powerful cancer biomarker: circulating tumor DNA (ctDNA). The company was founded in 2016 as a spin-out from a highly successful research group at Lund University, with a mission to improve precision cancer medicine, provide more accurate treatment monitoring, and improve patient survival using minimally-invasive liquid biopsy cancer testing services and kits. The S

    Repeat Founder
    Top 100 in Genetics
    Company Highlights
    Year Founded

    2016

    icon-altEmployees

    66

    Location (HQ)

    USA

    Since Last Funding

    3 years 2 months

    Monthly Website Visitors

    3.5K

    icon-altTotal Investment Amt

    $18M

    Last Funding Round

    Series A

    icon-altMoM Headcount Growth

    -1.49%

    icon-altYoY Headcount Growth

    49.89%

    Key Metrics

    Senior Hires

    NameLinkedin ProfilePositionDate Joined
    John Doehttps://www.linkedin.com/in/johndoeCEOCEO
    Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
    John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
    Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
    Get API access to complete private company database with growth metrics from 15 sources

    Similar Companies

    Medical

    Biotechnology

    Biotechnology Research

    Oncology

    Genetics